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During the 1990–1991 Gulf War (GW),
approximately 700,000 U.S. troops were
deployed to the Persian Gulf theater of opera-
tions. Large-scale involvement of U.S. forces
in combat in this region largely ended by the
winter of 1991. Nevertheless, significant
numbers of the 700,000 U.S. service person-
nel deployed to the region in 1990–1991 pre-
sented with medical complaints in the years
following operations. Of that number,
approximately 100,000 have presented medi-
cal complaints through various registry and
examination programs (Brown et al. 2002;
Stuart et al. 2002). The symptomatology that
characterizes their complaints has been
described in a number of studies, including
investigations from the United Kingdom and
other countries (Iowa Persian Gulf Study
Group 1997; Lashof and Cassells 1998;
Perisan Gulf Veterans Coordinating Board
1995; Unwin et al. 1999). These studies of
both randomly sampled and selected popula-
tions show that GW veterans clearly report
both increased numbers and severity of virtu-
ally all symptoms queried when compared
with personnel not deployed to the region.
Signiﬁcantly, to date, these symptoms are not
reliably associated with characteristic signs or
diagnoses of pathological conditions (Eisen
et al. 2005; Fukuda et al. 1998; Hodgson and
Kipen 1999; Wessely 2004).
Only one study has made an attempt to
longitudinally follow GW veterans to deter-
mine how their symptomatic presentations
have evolved—whether there has been
improvement, stability, or decline in the self-
reported health of individuals and groups of
GW veterans (Hotopf et al. 2003, 2004).
This information is critical in trying to
understand not just the etiology of such com-
plaints but also how to plan for continued
care and rehabilitation.
We have studied, both clinically and by
survey, various groups of GW veterans since
1995 (Fiedler et al. 2006; Hallman et al.
2003; Kipen et al. 1999; Peckerman et al.
1999; Pollet et al. 1998). Our original investi-
gations were from a random sample of the
Department of Veterans Affairs (VA) GW
registry members. We found that physician
diagnoses, including those without a generally
accepted etiology such as chronic fatigue syn-
drome, multiple chemical sensitivities, and
ﬁbromyalgia, could not account for much of
the symptomatology presented and that, based
on symptom endorsement and severity, veter-
ans on the registry could be robustly classiﬁed
as either highly symptomatic (40% of sub-
jects) or mildly symptomatic (60% of sub-
jects) (Hallman et al. 2003). The large
number of highly symptomatic “cases” (i.e.,
self-reported sick individuals), as well as repre-
sentation from all four service branches,
including National Guard and Reserve units,
makes the VA registry a robust population
from which to investigate the characteristics,
although not the prevalence, of GW illnesses.
We are currently studying more representative
random populations of GW veterans (Fiedler
et al. 2006). As part of this random sample of
deployed and nondeployed veterans surveyed
in 2000, we took advantage of the opportu-
nity to do a 5-year follow-up of our original
cohort of individuals from the registry. We
hypothesized that the symptom reporting
would remain relatively constant over the
5-year frame and that the highly symptomatic
cluster would show a greater tendency toward
decline in their health status (more sympto-
matology) after controlling for demographic
variables. 
Materials and Methods
Participants. Participants were U.S. military
veterans from the Gulf War Health Registry
maintained by the VA. In 1995 (time 1), vet-
erans residing in seven states—Delaware,
Illinois, New Jersey, New York, North
Carolina, Ohio, and Pennsylvania—were
selected by VA’s Environmental Epidemiology
Service using a simple random sampling pro-
cedure. The veterans were originally selected
as part of recruitment for clinical studies of
GW illness (Hallman et al. 2003; Nelson
et al. 2001; Pollet et al. 1998). A random
subset of veterans who completed that survey
formed the sampling frame for the present
study conducted in 2000 (time 2). 
Procedure. At time 1, we mailed introduc-
tory letters and questionnaires with postage-
paid response envelopes to 2,011 veterans. We
followed this with reminder postcards, a sec-
ond (identical) letter and questionnaire, and a
maximum of three follow-up phone calls at
intervals of approximately 2 weeks until a
response was received, ultimately yielding
1,161 responses (60%).
At time 2, The U.S. Department of
Defense’s Defense Manpower Data Center
(DMDC) provided updated addresses and
demographic information on those who had
responded at time 1. These veterans were sent
a letter describing the project and requesting
their consent to be interviewed. Records from
the Internal Revenue Service and national
directory assistance databases (e.g., TeleMatch,
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BACKGROUND: During the 1990–1991 Gulf War, approximately 700,000 U.S. troops were deployed
to the Persian Gulf theater of operations. Of that number, approximately 100,000 have presented
medical complaints through various registry and examination programs.
OBJECTIVES: Widespread symptomatic illness without deﬁning physical features has been reported
among veterans of the 1991 Gulf War. We ascertained changes in symptom status between an initial
1995 symptom evaluation and a follow-up in 2000.
METHODS: We assessed mailed symptom survey questionnaires for 390 previously surveyed members
of the U.S. Department of Veterans Affairs Gulf War Registry for changes over the 5-year interval in
terms of number and severity of symptoms.
RESULTS: For the cohort as a whole, we found no signiﬁcant changes in symptom number or severity.
Those initially more symptomatic in 1995 showed some improvement over time, but remained much
more highly symptomatic than those who had lesser initial symptomatology.
CONCLUSIONS: The symptom outbreak following the 1991 Gulf War has not abated over time in
registry veterans, suggesting substantial need for better understanding and care for these veterans.
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Research | Environmental MedicineSpringﬁeld, VA) were used to locate veterans
whose letters were returned without forward-
ing information. These databases did not
include cellular telephone numbers.
This 5-year follow-up of the registry
cohort was included as a part of a larger inves-
tigation of a national random sample of
deployed GW veterans (Fiedler et al. 2006).
As part of this study, after informed consent
was obtained, all subjects were interviewed by
a computer-assisted telephone interview
(CATI) method. However, to allow direct fol-
low-up comparisons to the data collected by
mail at time 1 and to compare data collection
modalities, 60% of those in our original reg-
istry cohort were randomly mailed a one-page
questionnaire, comprising only symptom
questions, 2 weeks before their telephone
interview (Brewer et al. 2004). The veterans
reported an average of ﬁve more symptoms via
mail than via telephone, mainly as the result of
mild symptoms reported by mail that were not
reported at all during the telephone interview
(Brewer et al. 2004). As a result, we used this
one-page written symptom questionnaire as
the basis of our comparisons. Additional
demographic and other health information
was collected as part of the subsequent CATI
interview.
Measures. Participants were asked to exam-
ine a list of 48 symptoms identical to that used
at time 1 (Table 1). For each symptom, the
respondents indicated whether they had experi-
enced “persistent or recurring” problems
within the last 6 months, and if so, whether
the problems they had experienced were
“mild,” “moderate,” or “severe.” For each
symptom, a severity index was calculated by
coding “no” as 0, “mild” as 1, “moderate” as 2,
and “severe” as 3.
Based on factor and cluster analyses of their
time 1 symptom data, each respondent had
been classiﬁed as belonging to one of two clus-
ters: a) veterans reporting good health and few
moderate/severe symptoms (n = 242; ~ 60%),
and b) veterans reporting fair/poor health and
endorsing an average of 37 symptoms, 75% as
moderate/severe (n = 148; ~ 40%). Thus, there
was a total of 390 respondents who completed
both the time 1 and time 2 symptomatology
assessments (Table 2) (Hallman et al. 2003). 
Statistical analyses. To assess changes in
symptoms over time, we conducted paired sam-
ples t-tests on the average number of symptoms
and average severity of symptoms endorsed at
time 1 and time 2. We performed repeated
measures MANCOVA (multiple analysis of
covariance) to examine the main effect of time
on the severity of 48 symptoms by controlling
for age (mean centered), rank, race, marital sta-
tus, sex, education, branch of service, duty
(active or National Guard/Reserve), smoker
status, and cluster membership (“mildly” or
“highly” symptomatic as classiﬁed at time 1).
In addition, we performed an ANCOVA
(analysis of covariance) to examine the main
effect of cluster membership at time 1 on
change in number of symptoms over the
5-year period. The change score was calcu-
lated by subtracting time 1 scores from time 2
scores. We used the following variables as
controls: age (mean centered), sex, rank, race,
marital status, education, branch, duty, and
smoking status. For tests of main effects and
interactions, we adopted p < 0.05 as the criti-
cal value. To adjust for multiple comparisons
when comparing changes in the 48 individual
symptoms, we employed a Bonferroni correc-
tion, adopting as a critical value p < 0.001
(0.05/48). 
Results 
Response rates. Time 1. The results for time 1
have been fully described by Hallman et al.
(2003). Of the 1,935 deliverable question-
naires, 1,161 were completed and returned by
the respondents, yielding a response rate of
60%. Using chi-square analyses, we tested for
potential selection biases and found no signiﬁ-
cant differences in the distribution of branch of
service, duty status (active, Reserve, National
Guard), or sex between those randomly
selected to be in the sample and those in the
registry as a whole.
Logistic regression analyses suggested no
significant differences in response rates 
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Table 1. Severity (mean ± SD) of 48 symptoms at time 1 and time 2 for highly symptomatic and mildly sympto-
matic clusters and overall means.
Mild High
Time 1  Time 2  Time 1  Time 2  Overall mean 
Symptom (n = 242) (n = 242) (n = 148) (n = 148) Time 1/time 2
Headaches  0.85 ± 0.98 0.85 ± 0.97 2.11 ± 0.91 1.77 ± 0.98* 1.33/1.20
Eyes or vision 0.51 ± 0.79 0.67 ± 0.83 1.36 ± 0.94 1.45 ± 0.94 0.83/0.96
Ears or hearing 0.55 ± 0.83 0.69 ± 0.89 1.37 ± 1.05 1.30 ± 1.01 0.86/0.93
Nose or sinuses 0.86 ± 1.02 0.94 ± 1.01 1.86 ± 1.07 1.74 ± 1.11 1.24/1.25
Multiple chemical sensitivities 0.39 ± 0.74 0.51 ± 0.86 1.51 ± 1.12 1.57 ± 1.17 0.81/0.92
Mouth, teeth, and gums 0.41 ± 0.75 0.50 ± 0.83 1.25 ± 1.11 1.22 ± 1.08 0.73/0.77
Ability to taste 0.06 ± 0.26 0.12 ± 0.39 0.69 ± 0.90 0.70 ± 0.89 0.30/0.34
Difﬁculty swallowing 0.11 ± 0.41 0.21 ± 0.56 0.72 ± 0.85 0.73 ± 0.93 0.34/0.41
Throat problems 0.22 ± 0.55 0.26 ± 0.64 1.03 ± 1.04 0.84 ± 0.94 0.53/0.48
Swollen glands 0.18 ± 0.46 0.25 ± 0.58 1.01 ± 1.05 0.79 ± 0.94 0.49/0.46
Difﬁculty breathing 0.33 ± 0.66 0.36 ± 0.69 1.45 ± 1.00 1.03 ± 0.95* 0.75/0.62
Coughing  0.38 ± 0.65 0.46 ± 0.74 1.39 ± 1.07 1.21 ± 1.06 0.76/0.74
Chest discomfort 0.43 ± 0.74 0.48 ± 0.75 1.56 ± 0.94 1.33 ± 1.01 0.86/0.80
Irregular heartbeat 0.16 ± 0.52 0.29 ± 0.62 0.71 ± 1.03 0.71 ± 0.91 0.37/0.45
Arms, hands, and shoulders 0.55 ± 0.87 0.67 ± 0.87 1.82 ± 1.08 1.63 ± 1.03 1.03/1.03
Back problems 0.70 ± 0.90 0.86 ± 0.98 1.78 ± 1.01 1.75 ± 1.11 1.11/1.20
Nausea  0.18 ± 0.45 0.21 ± 0.56 0.99 ± 0.95 0.84 ± 0.93 0.49/0.45
Vomiting  0.05 ± 0.25 0.09 ± 0.40 0.47 ± 0.77 0.39 ± 0.73 0.21/0.20
Stomach or digestive problems 0.52 ± 0.86 0.69 ± 0.93 1.59 ± 1.07 1.53 ± 1.08 0.93/1.01
Diarrhea  0.39 ± 0.73 0.48 ± 0.80 1.29 ± 1.08 1.21 ± 1.08 0.73/0.76
Constipation  0.17 ± 0.51 0.24 ± 0.57 0.61 ± 0.85 0.74 ± 0.95 0.33/0.43
Abdominal gas 0.54 ± 0.81 0.72 ± 0.95* 1.74 ± 1.05 1.54 ± 1.10 0.99/1.03
Abdominal pain 0.29 ± 0.66 0.42 ± 0.74 1.41 ± 0.98 1.26 ± 1.04 0.72/0.74
Frequent or painful urination 0.16 ± 0.46 0.24 ± 0.66 0.74 ± 0.95 0.69 ± 0.90 0.38/0.41
Muscle aches or cramps 0.57 ± 0.81 0.82 ± 0.93* 1.95 ± 0.86 1.81 ± 1.06 1.09/1.19
Sexual or genital problems 0.21 ± 0.52 0.28 ± 0.67 0.97 ± 1.12 0.93 ± 1.10 0.50/0.53
Numbness or tingling 0.47 ± 0.73 0.70 ± 0.86* 1.80 ± 0.89 1.72 ± 1.08 0.97/1.08
Pain in arms and legs 0.57 ± 0.82 0.79 ± 0.95* 2.11 ± 0.87 1.88 ± 1.06 1.15/1.20
Pain in more than one joint 0.71 ± 0.92 0.86 ± 0.99 2.17 ± 0.88 2.05 ± 1.00 1.27/1.31
Skin (including rashes) 0.74 ± 0.95 0.68 ± 0.98 1.69 ± 1.12 1.37 ± 1.15 1.10/0.94
Hair problems 0.18 ± 0.51 0.21 ± 0.61 0.81 ± 1.03 0.72 ± 1.00 0.42/0.40
Cuts or sores 0.34 ± 0.66 0.33 ± 0.70 1.04 ± 1.06 0.91 ± 1.06 0.61/0.55
Fainting spells 0.05 ± 0.26 0.06 ± 0.29 0.32 ± 0.73 0.24 ± 0.56 0.15/0.13
Losing balance/dizziness 0.38 ± 0.64 0.52 ± 0.77 1.43 ± 1.04 1.27 ± 0.93 0.78/0.80
Difﬁculty concentrating  0.62 ± 0.81 0.81 ± 0.89* 1.99 ± 0.90 1.87 ± 0.91 1.14/1.21
Difﬁculty remembering 0.81 ± 0.90 1.04 ± 0.94 2.13 ± 0.88 2.11 ± 0.94 1.31/1.45
Feeling sickly 0.31 ± 0.59 0.42 ± 0.74 1.59 ± 0.98 1.37 ± 0.99 0.80/0.78
Unrefreshing sleep 1.01 ± 0.95 1.14 ± 0.97 2.48 ± 0.73 2.26 ± 0.83* 1.57/1.57
Sleeping more than usual 0.54 ± 0.82 0.54 ± 0.86 1.62 ± 1.21 1.28 ± 1.20* 0.95/0.82
Fatigue (not from exercise) 0.92 ± 0.87 1.04 ± 0.98 2.34 ± 0.81 2.18 ± 0.81 1.46/1.47
Fatigue after exercise 0.37 ± 0.71 0.55 ± 0.86 1.82 ± 1.06 1.74 ± 1.13 0.92/1.00
Unexplained weakness 0.39 ± 0.64 0.48 ± 0.79 1.91 ± 0.98 1.72 ± 1.04 0.96/0.95
Feeling anxious 0.61 ± 0.76 0.71 ± 0.91 2.00 ± 0.95 1.74 ± 1.01 1.14/1.10
Sudden mood changes 0.64 ± 0.81 0.72 ± 0.90 2.11 ± 1.02 1.80 ± 1.07* 1.20/1.13
Sensitivity to heat or cold 0.37 ± 0.71 0.44 ± 0.80 1.49 ± 1.18 1.34 ± 1.18 0.79/0.78
Fever or chills 0.14 ± 0.42 0.19 ± 0.52 1.09 ± 1.05 0.84 ± 0.92 0.50/0.44
Sweating 0.31 ± 0.73 0.48 ± 0.84 1.39 ± 1.10 1.28 ± 1.11 0.72/0.79
Feeling depressed or blue 0.59 ± 0.80 0.71 ± 0.98 1.95 ± 1.00 1.61 ± 1.09* 1.11/1.05
*Signiﬁcantly different from time 1 to time 2 within highly symptomatic and mildly symptomatic clusters.attributable to sex, date of entry into the regis-
try, branch of service, type of duty (active,
Reserve, or National Guard), or rank [enlisted,
noncommissioned officer (NCO), warrant
ofﬁcer, ofﬁcer]. Multivariate analysis of vari-
ance also revealed no signiﬁcant differences in
response rates attributable to either specific
symptoms or speciﬁc diagnoses as determined
by VA examining physicians and independent
questionnaires completed at the time of reg-
istry enrollment (generally, months to years
prior to time 1 study).
Time 2. Updated DMDC data and data
collected by telephone indicated that 70 of the
original 1,161 registry veterans were ineligible
to participate in the follow-up study. These
included veterans who were deceased (n = 20),
not deployed to the Gulf (n = 39), incarcerated
(n = 3), or incapacitated (e.g., loss of hearing;
n = 8). Of the remaining 1,091 eligible to par-
ticipate, 640 (60%) were mailed a question-
naire, of which, 453 (71%) were completed
and returned. Forty-five (7%) could not be
delivered, and no forwarding address could be
found. Of those who completed the question-
naire, 426 were contacted by telephone and by
mail, and 398 of these completed both time 1
and time 2 assessments. Thus, 62% of those
mailed a questionnaire at time 2 completed it
and the subsequent telephone interview.
Eight cases were excluded because of miss-
ing data or because the demographic cate-
gories to which they belonged were too small
to permit meaningful analyses. These included
three veterans who served in the Coast Guard,
one widowed veteran, three who indicated the
“other” category for race, and one for whom
rank was unknown, leaving 390 subjects for
further analysis.
These 390 respondents did not differ sig-
nificantly from the 1,161 respondents who
participated at time 1 in terms of sex (8.5%
females vs. 9.6% of total); rank (12.6% ofﬁcers
vs. 10.1% of total); duty status at mobilization
(57.5% active vs. 59.0% of total); or branch
(70.0% Army vs. 70.2% of total). They were
signiﬁcantly different from the 1,161 originally
studied in terms of age at time 2 (42.7 years vs.
41.7 years for total), racial composition
(16.9% African American vs. 23.2% of total;
p < 0.006, two-sided), and education (22.8%
college graduates vs. 19.1% of total; p < 0.02).
In addition, t-tests with Bonferroni correction
revealed no signiﬁcant differences in the num-
ber of symptoms or their average severity
reported at time 1 by the 390 current respon-
dents and the remainder of the time 1 cohort.
Change in number of reported symptoms
over time. At time 1, the mean number of
symptoms (± SD) reported by the sample of
390 was 22.07 ± 12.92. At time 2, the mean
number of symptoms increased slightly (0.67
symptoms) to 22.74 ± 12.89; however, this
change was not significant [t(389) = –1.48;
p = 0.14]. Average symptom severity also
increased slightly from 0.83 ± 0.62 at time 1 to
0.84 ± 0.62 at time 2. Again, this change was
not significant [t(398) = –0.52; p = 0.61].
Results of ANCOVA on change in number of
symptoms controlling for age (mean centered),
sex, rank, race, marital status, education,
branch, duty, and smoking status revealed that
the effect of time 1 cluster membership was
significant [F(1, 379) = 31.84; p < 0.001]
(Table 3). Those veterans classiﬁed as mildly
symptomatic at time 1 showed an increase in
number of symptoms over time (mean, 2.33),
and those veterans who were highly sympto-
matic showed a decrease in symptoms at time 2
(mean, –2.04). Also, there were significant
effects of race [F(1, 379) = 15.11; p < 0.001]
and age [F(1, 379) = 6.98; p < 0.05]. Black
veterans reported 4.26 more symptoms at
time 2, whereas white veterans showed a slight
decrease [t(388) = –3.62; p < 0.001]. Increase
in the number of symptoms over time was
associated with older age (r = 0.12; p < 0 .05).
Changes in symptom severity over time. A
repeated measures MANCOVA indicated that
there was no signiﬁcant difference over time in
the severity of the 48 symptoms. However, we
observed multivariate effects on severity for
age [Wilks’s Λ = 0.756; F(48, 332) = 2.24; p <
0.001], race [Wilks’s Λ = 0.803; F(48,
332) = 1.70; p < 0.005], and cluster member-
ship [Wilks’s Λ = 0.344; F(48, 332) = 13.19;
p < 0.001] (Table 1). In addition, there was a
signiﬁcant time × smoker status effect [Wilks’s
Λ = 0.815; F(48, 332) = 1.57; p < 0.05] and a
significant time × cluster membership effect
[Wilks’s Λ = 0.790; F(48, 332) = 1.84;
p < 0.005].
Next, we looked at tests of between-subject
effects for the variables that yielded signiﬁcant
multivariate tests to examine the severity
changes in individual symptoms. The main
effect of age was signiﬁcant for “persistent or
recurring problems” with “arms, hands, and
shoulders,” “back problems,” “frequent or
painful urination,” “sexual or genital prob-
lems,” “pain in arms or legs,” and “pain in
more than one joint,” with the severity of all
these symptoms increasing more in older indi-
viduals. The main effect of race was signiﬁcant
for “persistent or recurring problems” with
“constipation,” “hair,” and “sweating not due
to exercise,” with all three symptoms increasing
more in severity among African-American vet-
erans (Table 4). The main effect of cluster
membership was signiﬁcant for “persistent or
Persistence of Gulf War symptoms
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Table 2. Demographic characteristics of the sample
(n = 390).
Demographic variable No. (%)
Sex 
Male 364 (93.3)
Female 26 (6.7)
Military branch
Army 267  (68.5)
Air Force  35 (9.0)
Marines 64  (16.4)
Navy 24  (6.2)
Education
High school  108 (27.7)
College 231  (59.2)
Graduate school  51 (13.1)
Duty
Active duty  227 (58.2)
National Guard  72 (18.5)
Reserves 91  (23.3)
Race
White 324 (83.1)
Black 66  (16.9)
Marital status
Married 217  (55.6)
Divorced 19  (4.9)
Separated 13  (3.3)
Single, never married  132 (33.8)
Not married but living with mate  9 (2.3)
Rank
Enlisted 183 (46.9)
NCO 157 (40.3)
Warrant ofﬁcer 8 (2.1)
Commissioned ofﬁcer 42 (10.8)
Smoker
Never smoked 178 (45.6)
Former smoker 111 (28.5)
Current smoker 101 (25.9)
Table 3. Number of symptoms (mean ± SD) at time
1 and time 2 across demographic variables and
cluster membership.
Demographic variable Time 1 Time 2
Cluster membership
Mildly symptomatic  14.22 ± 8.67 16.55 ± 10.49
Highly symptomatic  34.90 ± 7.15 32.86 ± 9.64
Sex 
Male  22.02 ± 12.96 22.81 ± 12.96
Female  22.73 ± 12.57 21.81 ± 12.03
Military branch
Army  23.47 ± 12.46 24.14 ± 12.76
Air Force  23.60 ± 12.39 23.66 ± 12.09
Marines  16.72 ± 13.86 18.14 ± 13.44
Navy  18.54 ± 12.44 18.13 ± 10.55
Education
High school  23.62 ± 13.12 24.31 ± 12.79
College  22.45 ± 12.95 23.42 ± 13.01
Graduate school  17.04 ± 11.24 16.33 ± 10.65
Duty
Active duty  22.77 ± 13.22 23.26 ± 12.93
National Guard  21.42 ± 11.78 23.04 ± 11.93
Reserves 20.83 ± 13.01 21.20 ± 13.50
Race
White 21.47 ± 12.68 21.41 ± 12.45
Black  25.00 ± 13.77 29.26 ± 13.12
Marital status
Married  22.77 ± 13.18 23.75 ± 13.17
Divorced  25.53 ± 13.79 25.26 ± 13.77
Separated  21.00 ± 13.48 23.62 ± 13.74
Single, never married 20.64 ± 12.26 20.40 ± 12.14
Not married but  20.22 ± 13.34 26.11 ± 11.21
living with mate
Rank
Enlisted  21.54 ± 12.99 21.71 ± 12.69
NCO 23.85 ± 12.82 25.50 ± 13.14
Warrant ofﬁcer  19.13 ± 16.14 22.25 ± 13.81
Full ofﬁcer  18.29 ± 11.56 17.00 ± 10.16
Smoker
Never smoked  20.92 ± 13.15 20.87 ± 13.12
Former smoker  21.24 ± 13.17 23.19 ± 12.69
Current smoker 25.00 ± 11.85 25.54 ± 12.25Ozakinci et al.
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recurring problems” with all 48 symptoms at
the p < 0.001 level, with F(1, 379) values rang-
ing from 32.96 to 329.59. Veterans who were
highly symptomatic at time 1 had higher sever-
ity scores at time 2 than those who reported
mild symptomatology.
The time × smoker status interaction term
revealed that it was signiﬁcant for “persistent or
recurring problems” with “mouth, teeth,
gums” (Table 4). Paired samples t-tests showed
that while the changes in this symptom were
not significant for those who never smoked
and for former smokers, the increase in symp-
tom severity for the current smokers was signif-
icant [t(100) = –3.37; p < 0.005]. The time ×
cluster membership interaction term was sig-
niﬁcant for “persistent or recurring problems,”
with 18 symptoms listed in Table 4. Paired
samples t-tests for 18 symptoms for the cluster
originally reporting mild symptomatology
showed that after Bonferroni correction
(0.05/18 = 0.002), the increases over time in
the severity of “abdominal gas,” “muscle aches
or cramps,” “numbness or tingling sensations,”
“pain in arms or legs,” and “difﬁculty concen-
trating” were signiﬁcant. For the cluster that
reported high symptomatology at time 1, the
decreases in the severity of “headaches,” “difﬁ-
culty breathing,” “unrefreshing sleep,” “sleep-
ing more than usual,” “sudden mood changes,”
and “feeling depressed or blue” were signiﬁcant
after Bonferroni correction (means ± SDs
presented in Table 1).
Discussion
Consistent with our hypothesis, this group of
Gulf War Registry veterans continued to expe-
rience significant symptoms 10 years after
deployment to the Middle East, > 5 years after
they presented for registry examination. In the
cohort as a whole, we found no significant
changes in individually matched symptom
reporting, neither improvement nor progres-
sion, in number or severity of symptoms.
However, some subgroups did show signifi-
cant, albeit relatively small, changes. Important
predictors of worsening included being less
symptomatic at time 1, African-American race,
older age, and being a smoker at time 2. The
effects of older age and smoking seem logical
based on their expected impact on musculo-
skeletal changes and on oral health, respec-
tively. However the effects of race and cluster
are less straightforward.
Those who were classified as highly
symptomatic at time 1 had higher severity
scores compared with those who were mildly
symptomatic at both times. However, for
18 symptoms we did observe a time × cluster
effect; this time × cluster effect showed that a
subset of symptoms in mildly symptomatic
people increased severity over time, whereas a
distinct subset of symptoms in highly sympto-
matic people decreased severity over time. In
spite of the increase in symptom number and
severity for the mild cluster and the decrease
for the high cluster, the individuals in the two
groups still remain substantially apart and dis-
tinct, with high individuals maintaining high
symptomatology over time. 
A history of physician diagnoses did not
predict symptoms at time 1 (Hallman et al.
2003), so we did not include this data in these
subsequent analyses. Prior medical evaluations
of GW veterans have not demonstrated
explanatory medical findings or diagnoses
between those with and without symptoms
(Eisen et al. 2005; Fukuda et al. 1998;
Hodgson and Kipen 1999; Wessely 2004).
Controlled trials of behavioral therapy
and antibiotics for Gulf War illness have been
conducted, and some of our subjects likely
participated in both routine and experimental
therapies. However, based on reports from
therapeutic trials to date, there is little reason
to expect a large effect of treatment on symp-
toms (Donta 2004; Wessely 2004).
Hotopf et al. (2003) measured total symp-
toms in a random-sample U.K. Gulf War vet-
eran cohort in 1997 and again in 2001. They
reported a nonsignificant decrease in symp-
toms over the 4 years, consistent with our
finding of only minor variation. Using a
fatigue scale, a psychiatric distress scale
(General Health Questionnaire) and a measure
of physical function (Medical Outcome Study
Short-Form 36), Hotopf et al. (2004) reported
that greater initial severity of fatigue predicted
greater severity for all three outcomes over a
5-year follow-up. This is somewhat contrary
to our ﬁndings that more symptomatic indi-
viduals actually showed greater declines in
symptomatology. This difference may be
explained by their use of scales for specific
conditions rather than unaggregated symp-
tom data, as we used. They also found that
the attribution factor “Belief in Gulf War
Syndrome” was associated with worsening,
which is consistent with our previous ﬁndings
at time 1 (Boyd et al. 2003). 
Limitations. The veterans we studied were
taken from a registry and thus may not be
completely representative of all deployed sol-
diers. We did not have a comparison group
that was not deployed in this analysis, but we
used individual matching to avoid many
sources of bias, and all analyses were adjusted
for multiple potential demographic con-
founders. Self-report items are always subject
to bias; also, the interpretation of symptoms
in the absence of explanatory diagnoses
remains a challenge, but cannot be avoided
until more reliable biomarkers of such ill-
nesses are developed.
Implications. Overall, we found little
change to indicate either a self-limited condi-
tion or one characterized by significant pro-
gression. Although this does not have clear
implications in terms of etiology, it does sug-
gest that continued efforts to find effective
treatments and understand etiologies(s) are
relevant in the absence of substantial
improvement in the severity and number of
symptoms experienced by Gulf War veterans
over time.
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